biotech · Colorectal Cancer · Psoriatic Arthritis, Rheumatoid Arthritis · CRDF
Cardiff Oncology
Cardiff Oncology clinical programs — 8 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 11055 Flintkote Avenue, San Diego, California 92121, US
- Founded
- 1999
- Employees
- 51
- Programs
- 58
- Drugs
- 62
- Patents
- 69
Cardiff Oncology projects
8 ClinicalTrials.gov programs sponsored by Cardiff Oncology.
Cardiff Oncology has 8 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Arm A Mylotarg plus DA Versus CPX-351
Cardiff Oncology
Acute Myeloid Leukaemia
1 trial -
Azithromycin
Cardiff Oncology
Bronchopulmonary Dysplasia
1 trial -
CISPLATIN, CARBOPLATIN
Cardiff Oncology
Human papillomavirus (HPV)-positive oropharyngeal cancer
1 trial -
Intravenous Methylprednisolone
Cardiff Oncology
Myelitis, Transverse
1 trial -
Mycophenolate Mofetil
Cardiff Oncology
Immune Thrombocytopenia
1 trial -
Oral triiodothyronine
Cardiff Oncology
Postoperative; Dysfunction Following Cardiac Surgery
1 trial -
Tetronine
Cardiff Oncology
Postoperative; Dysfunction Following Cardiac Surgery
1 trial -
mesalazine (Asacol®)
Cardiff Oncology
Ulcerative Colitis
1 trial
Frequently asked questions
How many clinical projects does Cardiff Oncology have?
8 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.